Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-13

Clinical Trial Update: Effect of Acetyl-L-carnitine in Migraine [Phase 4]

View source ↗

Summary

Phase 4 trial update on acetyl-L-carnitine for migraine has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acetyl-L-carnitine (N-acetyl-L-carnitine)

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Migraine | Phase 4 | Status: COMPLETED | Results posted: 2022-04-13